NFKB1 and pancreatic neoplasm: We have also demonstrated a significant role of NF-κB signaling in the development of gemcitabine resistance in pancreatic cancer through ROS-mediated activation of NF-κB and the subsequent upregulation of CXCR4-signaling, thereby promoting cell survival [27].